1	Se	se	P00CN000	-	-	0-2	223(2)_ANS_clinical_caseMIR	SENT1	-	-
2	trata	tratar	VMIP3S0	-	-	3-8	223(2)_ANS_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	9-11	223(2)_ANS_clinical_caseMIR	SENT1	-	-
4	una	una		C0205447_1	calificador_1	12-15	223(2)_ANS_clinical_caseMIR	SENT1	-	-
5	mononucleosis	mononucleosis	NCFN000	C0021345_1	trastorno_1	16-29	223(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
6	infecciosa	infeccioso	AQ0FS0	C0021345_2	trastorno_2	30-40	223(2)_ANS_clinical_caseMIR	SENT1	B-Calificador	-
7	de	de	SPS00	C0332285	atributo	41-43	223(2)_ANS_clinical_caseMIR	SENT1	-	-
8	curso	curso	NCMS000	C0750729	atributo#calificador	44-49	223(2)_ANS_clinical_caseMIR	SENT1	-	-
9	grave	grave	AQ0CS0	C0439808#C0205082	calificador	50-55	223(2)_ANS_clinical_caseMIR	SENT1	-	-
10	y	y	CC	C1706368	calificador	56-57	223(2)_ANS_clinical_caseMIR	SENT1	-	-
11	se	se	P00CN000	-	-	58-60	223(2)_ANS_clinical_caseMIR	SENT1	-	-
12	debe	deber	VMIP3S0	-	-	61-65	223(2)_ANS_clinical_caseMIR	SENT1	-	-
13	administrar	administrar	VMN0000	C1621583	calificador	66-77	223(2)_ANS_clinical_caseMIR	SENT1	-	-
14	glucocorticoides	glucocorticoide	NCMP000	C0017710	producto#sustancia	78-94	223(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
15	.	.	Fp	-	-	95-96	223(2)_ANS_clinical_caseMIR	SENT1	-	-

